20
Participants
Start Date
January 11, 2010
Primary Completion Date
October 30, 2018
Study Completion Date
October 30, 2018
autologous hematopoietic cell transplantation
"1. Autologous peripheral blood stem cell (PBSCs) harvesting~ * After the second cycle of high-dose ara-C(HDAC) consolidation chemotherapy~ * Mobilization: recombinant human G-CSF(Filgrastim) 5mcg/kg s.c. daily starting on 10 days after start of the second cycle of HDAC chemotherapy~ * Harvest procedure: peripheral blood mononuclear cells will be collected. Target CD34+ cell dose is over 5x10E6/kg.~2. Conditioning regimen for autologous HCT~ * Busulfan 3.2 mg/kg/day i.v. daily on days -7 to -5 (for 3 days)~ * Etoposide 400mg/m2/day i.v. daily on days -3 to -2 (for 2 days)~3. Autologous cell infusion and waiting for engraftment"
Hallym University Sacred Heart Hospital, Anyang
Wonkwang University Hospital, Iksan
Kosin University, Gospel Hospital, Busan
Busan Paik Hospital, Inje University College of Medicine, Busan
Gyeongsang National University Hospital, Jinju
Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan
Daegu Fatima Hospital, Daegu
Yeongnam University Hospital, Daegu
Daegu Catholic University Medical Center, Daegu
Gachon University Gil Hospital, Inchon
Asan Medical Center, Seoul
Lead Sponsor
Asan Medical Center
OTHER